GSK Pharmaceuticals felicitates key distribution partners in Sri Lanka

From left: GSK Country Head Sunder Ramachandran, Chandrasiri Pharmaceuticals Managing Director Chandrasiri Perera and GSK Head of Finance Manoj Jayawardena

The GSK team with the key distributors

The leadership team at GSK Pharmaceuticals Ltd. felicitated the key distribution partners at its office in Nawala. The objective of the meeting was to provide clarity on the 2022 business goals and priority areas for the distributors.

GSK Sri Lanka Country Head Sunder Ramachandran stated: “Our distribution partners play a key role in ensuring the last mile reach for our medicines and serve patients in Sri Lanka. They also provide us feedback on what can be improved to build a sustainable and strong business that creates a win-win proposition.”

The meeting saw participation from leading healthcare distributors like Chandrasiri Pharmaceuticals Ltd., DSN Enterprises Lanka Ltd., Kolitha Agencies, New Pharmacy & Company, The Pharmaco Ltd., Sri Lanka Pharmacy Ltd. and FTC Ventures Ltd.

Chandrasiri Perera from Chandrasiri Pharmaceuticals said: “We are confident about the business plans that GSK has for Sri Lanka and look forward to a close partnership. We also are proud to partner with them given their focus on quality and always doing the right thing.”

GSK is a leading multinational pharmaceutical company with a local country office and a history of over 40 years of serving patients and consumers in Sri Lanka. It has leading market positions in the anti-infective and vaccines area with a growing respiratory and dermatology portfolio.